Logo: Askel Healthcare: WhiteLogo: Askel Healthcare: White
  • Home
  • Company
    • About
    • Management
    • Careers
    • News
    • Events
    • For Media
  • Products
  • Professionals
    • Healthcare professionals
    • Clinical Advisory Board (CAB)
    • Research
  • Patients
  • Investors
    • Investors
    • Investor news
  • Contact
admin
2 posts

The European Commission’s European Innovation Council has selected Askel as an innovative start-up to receive EUR 2.5 million of funding

Askel Healthcare has been granted FDA Breakthrough Device Designation for COPLA®

Home
About
Management
Careers
News
Events
For media
Products
Professionals
Clinical Advisory Board (CAB)
Research
Patients
Investors
Investor news
Contact

Privacy notice
Cookie declaration

Askel Healthcare Ltd (Headquarters)
Siltasaarenkatu 8-10
00530 Helsinki
Finland

Askel Healthcare Ltd
Naulakatu 3
33100 Tampere
Finland

Get in touch
info@askelhealthcare.com
+358 40 489 3840

Co-funded by the European Union
Tissue Cure